Scalp psoriasis is an autoimmune condition that may be worsened by poor hygiene but isn’t caused by it A dermatologist ...

Although manuka honey may not treat the underlying cause of psoriasis, research suggests it may help reduce skin inflammation ...

The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Symptoms, lesion locations, and morphology are among the features clinicians may use to distinguish hand eczema from hand psoriasis in patients.

Certain biologic therapies, such as ustekinumab, significantly effect hematological and lipid parameters in patients with psoriasis.

Peter Dank, MD, Dermatologist, discusses What are Your Treatment Options for Psoriasis.

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...

Newseria nie ponosi odpowiedzialności za treści oraz inne materiały (np. infografiki, zdjęcia) przekazywane w „Biurze Prasowym”, których autorami są zarejestrowani użytkownicy tacy jak agencje PR, ...

It can take up to a year for toenail fungus to completely resolve with treatment, and it can come back without proper ...

The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) topical foam 0.3% for the ...

ZORYVE foam allows patients to treat their whole body with one prescription, transforming the treatment landscape for scalp and body psoriasis.” “Individuals living with psoriasis, a chronic ...